Jennifer Sy

Insider Reports History

Location
C/O Aeon Biopharma, Inc., 5 Park Plaza, Suite 1750, Irvine, CA
Signature
/s/ Alexander Wilson, as attorney-in-fact for Jennifer Sy
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jennifer Sy:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AEON Biopharma, Inc. Chief Accounting Officer Restricted Stock Units 926K May 21, 2025 Direct
AEON Biopharma, Inc. Chief Accounting Officer Stock Option 48.1K Aug 31, 2024 Direct
AEON Biopharma, Inc. Chief Accounting Officer Class A Common Stock 18K Aug 31, 2024 Direct

Insider Reports Filed by Jennifer Sy

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AEON AEON Biopharma, Inc. May 21, 2025 1 $0 4 May 23, 2025 Chief Accounting Officer
AEON AEON Biopharma, Inc. Aug 31, 2024 2 $0 4 Sep 4, 2024 PRINCIPAL ACCOUNTING OFFICER
AEON AEON Biopharma, Inc. May 17, 2024 0 $0 3 May 24, 2024 PRINCIPAL ACCOUNTING OFFICER